and their efficacy and safety in the management of community-acquired pneumonia (CAP). Data show that CAP is a common presentation in primary care practice, and is associated with high rates of ...

Community-acquired pneumonia (CAP) is a systemic disease and continues to be the leading cause of infectious mortality ...

Lefamulin is a novel antibiotic that has recently gained attention for its effectiveness in treating community-acquired bacterial pneumonia (CABP). As antibiotic resistance continues to rise ...

Background The etiologic profile of community-acquired pneumonia (CAP) for each age group could be similar among inpatients and outpatients. This fact brings up the link between etiology of CAP ...

The use of corticosteroids in patients hospitalized for community-acquired pneumonia (CAP) lowers the risk of death by 30 ...

Community-acquired pneumonia (CAP ... "Inappropriate diagnosis and treatment of pneumonia may have implications, such as ...

A study in The Annals of Family Medicine explored how chest X-ray results influence antibiotic initiation by general practitioners in France when managing patients with suspected pneumonia.

The Indian drug regulator, Central Drugs Standard Control Organization (CDSCO) has approved Miqnaf (nafithromycin) as a new treatment for the Community-Acquired Bacterial Pneumonia (CABP) in Adults ...

Antibiotics can be used to treat a litany of illnesses, but one thing they can’t combat is a viral infection.